论文部分内容阅读
目的观察血清总前列腺特异性抗原(TPSA)在慢性前列腺炎临床诊断中的效果。方法选取2013年1月-2014年10月前列腺相关病变患者190例为研究对象,根据患者疾病情况分为A组(Ⅱ型30例)、B组(Ⅲa型28例)、C组(Ⅲb型32例)、E组(前列腺炎患者36例)、F组(前列腺增生患者42例)、G组(前列腺癌患者22例),另选取同期健康体检者30名为健康对照组(D组),分别监测各组患者血清TPSA水平,并进行比较。结果 A组、B组、C组、D组以及E组、F组、G组与D组分别在血清TPSA水平上比较,P<0.01,差异有统计学意义。结论血清TPSA水平检测可应用于临床诊断慢性前列腺炎以及疾病分型,具有临床意义。
Objective To observe the effect of serum total prostate specific antigen (TPSA) in the clinical diagnosis of chronic prostatitis. Methods Totally 190 patients with benign prostatic diseases were selected from January 2013 to October 2014. The patients were divided into group A (30 cases in type Ⅱ), group B (type Ⅲa 28 cases), group C (Ⅲ b 32 patients in group E), 36 patients in group E (42 patients with prostatitis), 22 patients in group F (22 patients with prostatic hyperplasia), 30 patients in group G (22 patients with prostate cancer), and 30 healthy controls (group D) The levels of serum TPSA in each group were monitored and compared. Results The level of serum TPSA in group A, group B, group C, group D, group E, group F, group G and group D were respectively compared with each other (P <0.01). The difference was statistically significant. Conclusion The detection of serum TPSA level can be used in the clinical diagnosis of chronic prostatitis as well as the type of disease, with clinical significance.